Lesuride OD 75 Tablet contains Levosulpiride 75 mg as its active ingredient, a selective dopamine D2 receptor antagonist primarily used for the treatment of gastrointestinal motility disorders and certain psychiatric conditions. Levosulpiride exerts prokinetic effects by enhancing gastric emptying and improving esophageal motility, making it effective in managing functional dyspepsia, gastroesophageal reflux disease (GERD), and delayed gastric emptying. Additionally, its antipsychotic properties are utilized in the treatment of schizophrenia and depressive disorders, particularly where dopaminergic dysfunction is implicated. Lesuride OD 75 Tablet is formulated as an orally disintegrating tablet, facilitating ease of administration and improved patient compliance, especially in individuals with swallowing difficulties. The drug is generally well-tolerated; however, potential side effects may include extrapyramidal symptoms, hyperprolactinemia, sedation, and gastrointestinal disturbances. Caution is advised in patients with a history of seizures, renal or hepatic impairment, and those concurrently receiving other dopamine antagonists or central nervous system depressants. Dosage and duration of therapy should be individualized based on clinical response and tolerability, under the supervision of a healthcare professional. Lesuride OD 75 Tablet should be stored in a cool, dry place, away from direct sunlight and out of reach of children.